BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9349501)

  • 1. Chimeric MLL products with a Ras binding cytoplasmic protein AF6 involved in t(6;11) (q27;q23) leukemia localize in the nucleus.
    Joh T; Yamamoto K; Kagami Y; Kakuda H; Sato T; Yamamoto T; Takahashi T; Ueda R; Kaibuchi K; Seto M
    Oncogene; 1997 Oct; 15(14):1681-7. PubMed ID: 9349501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of MLL and chimeric MLL gene products involved in 11q23 translocation and possible mechanisms of leukemogenesis by MLL truncation.
    Joh T; Kagami Y; Yamamoto K; Segawa T; Takizawa J; Takahashi T; Ueda R; Seto M
    Oncogene; 1996 Nov; 13(9):1945-53. PubMed ID: 8934541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of the rearranged genome and chimeric mRNAs caused by the t(6;11)(q27;q23) chromosome translocation involving MLL in an infant acute monocytic leukemia.
    Akao Y; Isobe M
    Genes Chromosomes Cancer; 2000 Apr; 27(4):412-7. PubMed ID: 10719372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLL-AF6 fusion oncogene sequesters AF6 into the nucleus to trigger RAS activation in myeloid leukemia.
    Manara E; Baron E; Tregnago C; Aveic S; Bisio V; Bresolin S; Masetti R; Locatelli F; Basso G; Pigazzi M
    Blood; 2014 Jul; 124(2):263-72. PubMed ID: 24695851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of an inducible expression system of chimeric MLL-LTG9 protein and inhibition of Hox a7, Hox b7 and Hox c9 expression by MLL-LTG9 in 32Dcl3 cells.
    Joh T; Hosokawa Y; Suzuki R; Takahashi T; Seto M
    Oncogene; 1999 Jan; 18(4):1125-30. PubMed ID: 10023690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation.
    Corral J; Forster A; Thompson S; Lampert F; Kaneko Y; Slater R; Kroes WG; van der Schoot CE; Ludwig WD; Karpas A
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8538-42. PubMed ID: 8378328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The localization of the HRX/ALL1 protein to specific nuclear subdomains is altered by fusion with its eps15 translocation partner.
    Rogaia D; Grignani F; Carbone R; Riganelli D; LoCoco F; Nakamura T; Croce CM; Di Fiore PP; Pelicci PG
    Cancer Res; 1997 Mar; 57(5):799-802. PubMed ID: 9041173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ENL, the MLL fusion partner in t(11;19), binds to the c-Abl interactor protein 1 (ABI1) that is fused to MLL in t(10;11)+.
    García-Cuéllar MP; Schreiner SA; Birke M; Hamacher M; Fey GH; Slany RK
    Oncogene; 2000 Mar; 19(14):1744-51. PubMed ID: 10777208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. t(10;11)-acute leukemias with MLL-AF10 and MLL-ABI1 chimeric transcripts: specific expression patterns of ABI1 gene in leukemia and solid tumor cell lines.
    Shibuya N; Taki T; Mugishima H; Chin M; Tsuchida M; Sako M; Kawa K; Ishii E; Miura I; Yanagisawa M; Hayashi Y
    Genes Chromosomes Cancer; 2001 Sep; 32(1):1-10. PubMed ID: 11477655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion of the MLL gene with two different genes, AF-6 and AF-5alpha, by a complex translocation involving chromosomes 5, 6, 8 and 11 in infant leukemia.
    Taki T; Hayashi Y; Taniwaki M; Seto M; Ueda R; Hanada R; Suzukawa K; Yokota J; Morishita K
    Oncogene; 1996 Nov; 13(10):2121-30. PubMed ID: 8950979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular localization of the MEN, MLL/MEN and truncated MLL proteins expressed in leukemic cells carrying the t(11;19)(q23;p13.1) translocation.
    Kanda Y; Mitani K; Tanaka T; Tanaka K; Ogawa S; Yazaki Y; Hirai H
    Int J Hematol; 1997 Aug; 66(2):189-95. PubMed ID: 9277049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the t(6;11)(q27;q23) in leukemia shows a consistent breakpoint in AF6 in three patients and in the ML-2 cell line.
    Tanabe S; Zeleznik-Le NJ; Kobayashi H; Vignon C; Espinosa R; LeBeau MM; Thirman MJ; Rowley JD
    Genes Chromosomes Cancer; 1996 Apr; 15(4):206-16. PubMed ID: 8703846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of AF4 wild-type and AF4.MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology?
    Bursen A; Moritz S; Gaussmann A; Moritz S; Dingermann T; Marschalek R
    Oncogene; 2004 Aug; 23(37):6237-49. PubMed ID: 15221006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia.
    Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD
    Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The LIM domain protein Lmo2 binds to AF6, a translocation partner of the MLL oncogene.
    Bégay-Müller V; Ansieau S; Leutz A
    FEBS Lett; 2002 Jun; 521(1-3):36-8. PubMed ID: 12067721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The FEL (AF-4) protein donates transcriptional activation sequences to Hrx-Fel fusion proteins in leukemias containing T(4;11)(Q21;Q23) chromosomal translocations.
    Morrissey JJ; Raney S; Cleary ML
    Leuk Res; 1997 Oct; 21(10):911-7. PubMed ID: 9403001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations.
    Drexler HG; Quentmeier H; MacLeod RA
    Leukemia; 2004 Feb; 18(2):227-32. PubMed ID: 14671638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures.
    Butler LH; Slany R; Cui X; Cleary ML; Mason DY
    Blood; 1997 May; 89(9):3361-70. PubMed ID: 9129043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paired multiplex reverse-transcriptase polymerase chain reaction (PMRT-PCR) analysis as a rapid and accurate diagnostic tool for the detection of MLL fusion genes in hematologic malignancies.
    Andersson A; Höglund M; Johansson B; Lassen C; Billström R; Garwicz S; Nilsson PG; Mitelman F; Fioretos T
    Leukemia; 2001 Aug; 15(8):1293-300. PubMed ID: 11480574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional inhibition of p53 by the MLL/MEN chimeric protein found in myeloid leukemia.
    Maki K; Mitani K; Yamagata T; Kurokawa M; Kanda Y; Yazaki Y; Hirai H
    Blood; 1999 May; 93(10):3216-24. PubMed ID: 10233872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.